Date :
Place : United States of America, La Jolla
Website :http://go.evvnt.com/2755765-0?pid=80
Contact Person:Rosie Andre
Description:
Successfully Integrate Novel Liquid Biopsies into Your Workflows to Rapidly Validate Clinical Biomarkers for Robust Diagnosis, Prognosis & Monitoring Strategies that Improve Cancer Patient Outcomes. Time: 13:00 - 17:00. Prices: USD 0.50 - USD 3999.00Deadline for abstracts/proposals : 18th February 2025
Organized By :
Keynote Speakers :
Conference Highlights :Home - 9th LBx for Precision Oncology Summit 2025
Join the 9th Liquid Biopsy for Precision Oncology Summit to uncover innovative technology and rapidly validate clinical biomarkers.
Over the past 12 months, liquid biopsy testing has continued to revolutionize diagnostics and personalized medicine; from the integration of AI and automation to elevate liquid biopsy capabilities, to the approval of MRD as an endpoint in Multiple Myeloma.
Cementing its position as the world’s leading forum for liquid biopsy specialists, the9th Liquid Biopsy for Precision Oncology Summitreturns to San Diego in February - with a refreshed agenda providing crucial insights spanning biomarker discovery to commercialization, and each critical step in between.
Whether you're new to the field or a seasoned expert, join over 250 of the industry’s top decision-makers fromAstraZeneca,Amgen,Eli Lilly,AbbVie,BLOODPAC,Boundless Bio, and more to ensure you and your team are equipped with the insights and connections needed to effectively integrate liquid biopsies into clinical trials and drive meaningful progress in precision oncology.
Executive Director
BLOODPAC
Check the event website for more details.